{{Drugbox
| IUPAC_name = 7-[(4-fluorobenzyl)amino]-8-methylnonanoic acid
| image = Zafuleptine.png

<!--Clinical data-->
| tradename = 
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number = 59209-97-1
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 68789
| ChemSpiderID = 62029
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = E697IIC25J

<!--Chemical data-->
| C=17 | H=26 | F=1 | N=1 | O=2
| molecular_weight = 295.39 g/mol
| smiles = Fc1ccc(cc1)CNC(CCCCCC(=O)O)C(C)C
}}

'''Zafuleptine''' ([[International Nonproprietary Name|INN]]) (proposed brand name '''Thymeon''') is an [[antidepressant]] developed in the mid-1970s which, despite apparently having a chosen brand name, was never marketed.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=A0THacd46ZsC&lpg=PA2145&ots=IIlmgKzd41&dq=thymeon%20zafuleptine&pg=PA2145#v=onepage&q=thymeon%20zafuleptine&f=false}}</ref>

==References==
{{Reflist|2}}


{{Antidepressants}}

[[Category:Amines]]
[[Category:Antidepressants]]
[[Category:Carboxylic acids]]
[[Category:Fluoroarenes]]


{{nervous-system-drug-stub}}